A I-Designed Compounds Can Kill Drug-Resistant Bacteria

Why It Matters

The team says the approach opens access to vast, previously unexplored chemical space for antibiotic discovery and could be applied to design drugs against other resistant pathogens, a significant advance given drug‑resistant infections cause an estimated 5 million deaths annually.

Summary

MIT researchers used generative artificial intelligence to design and computationally screen more than 36 million novel compounds, identifying two structurally distinct antibiotic candidates that kill multi‑drug‑resistant Neisseria gonorrhoeae and MRSA. The top molecules appear to act via a previously unseen membrane‑disrupting mechanism, which could make them less susceptible to existing resistance pathways. The team says the approach opens access to vast, previously unexplored chemical space for antibiotic discovery and could be applied to design drugs against other resistant pathogens, a significant advance given drug‑resistant infections cause an estimated 5 million deaths annually.